RLMD
Relmada Therapeutics Inc
Price:  
0.63 
USD
Volume:  
297,692.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLMD Fair Value

-1,910.42 %
Upside

What is the fair value of RLMD?

As of 2025-07-04, the Fair Value of Relmada Therapeutics Inc (RLMD) is -11.41 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.63 USD, the upside of Relmada Therapeutics Inc is -1,910.42%.

Is RLMD a good investment?

With the market price of 0.63 USD and our fair value calculation, Relmada Therapeutics Inc (RLMD) is not a good investment. Investing in RLMD stocks now will result in a potential loss of 1,910.42%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.63 USD
Stock Price
-11.41 USD
Fair Price
FAIR VALUE CALCULATION

RLMD Fair Value

Peter Lynch's formula is:

RLMD Fair Value
= Earnings Growth Rate x TTM EPS
RLMD Fair Value
= 5.00 x -2.28
RLMD Fair Value
= -11.41

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -59.46 -125.75 -157.04 -98.79 -79.98 -104.20
YoY growth -243.30% -111.49% -24.88% 37.09% 19.04% -64.71%

RLMD Fair Value - Key Data

Market Cap (mil) 20.91
P/E
Forward P/E
EPS -2.28
Avg earnings growth rate -64.71%
TTM earnings -75.71